PDB61 ECONOMIC EVALUATION OF LIRAGLUTIDE VS. ROSIGLITAZONE OR EXENATIDE FOR TYPE 2 DIABETES MELLITUS IN BULGARIA
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72119-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)72119-2/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
278
First Page :
A295
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72119-2&doi=10.1016/S1098-3015(11)72119-2